Ownership history in Alphabet Inc. · 13 quarters on record
This page tracks every 13F SEC filing in which Alphabet Inc. reported a position in Prime Medicine, Inc. (PRME). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 16,562,498 | — | 0% | 2.23% | $57.5M | $3.47 |
| 2025 Q3 | ADDED | 16,562,498 | +1,500,000 | +10.0% | 3.81% | $91.8M | $5.54 |
| 2025 Q2 | UNCHANGED | 15,062,498 | — | 0% | 1.74% | $37.2M | $2.47 |
| 2025 Q1 | UNCHANGED | 15,062,498 | — | 0% | 1.90% | $30.0M | $1.99 |
| 2024 Q4 | UNCHANGED | 15,062,498 | — | 0% | 2.56% | $44.0M | $2.92 |
| 2024 Q3 | UNCHANGED | 15,062,498 | — | 0% | 3.16% | $58.3M | $3.87 |
| 2024 Q2 | UNCHANGED | 15,062,498 | — | 0% | 3.92% | $77.4M | $5.14 |
| 2024 Q1 | ADDED | 15,062,498 | +3,200,000 | +27.0% | 4.19% | $105.4M | $7.00 |
| 2023 Q4 | UNCHANGED | 11,862,498 | — | 0% | 4.87% | $105.1M | $8.86 |
| 2023 Q3 | UNCHANGED | 11,862,498 | — | 0% | 7.27% | $113.2M | $9.54 |
As of 2025 Q4 — sorted by position size